Scaffold-stabilized L2 peptides as HPV vaccine
The thioredoxin-L2 vaccines consist of thioredoxin as a “scaffold” protein and one of several L2 peptide concatemers. The most effective peptides have been identified by epitope mapping; a positive corre-lation of the number of peptide units in the
concatemer with the titer of neutralizing antibodies has been shown.
Further Information: PDF
Deutsches Krebsforschungszentrum DKfZ
Phone: +49-6221-422958
Contact
Regina Otto
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…